Martifur MR 100mg Tablet contains Nitrofurantoin, a broad-spectrum antibacterial agent primarily used for the treatment and prophylaxis of urinary tract infections (UTIs). Nitrofurantoin exhibits bactericidal activity by inhibiting bacterial enzymes involved in carbohydrate metabolism and cell wall synthesis, effectively targeting common uropathogens such as Escherichia coli, Staphylococcus saprophyticus, and Enterococcus species. The modified-release formulation of Martifur MR ensures a sustained plasma concentration, enhancing therapeutic efficacy while minimizing dosing frequency, which improves patient compliance. It is indicated for acute uncomplicated cystitis, recurrent UTIs, and as a prophylactic measure in patients prone to recurrent infections. Martifur MR should be administered with food to improve absorption and reduce gastrointestinal side effects. Contraindications include patients with significant renal impairment, known hypersensitivity to nitrofurantoin, and during the last trimester of pregnancy due to the risk of hemolytic anemia in the newborn. Common adverse effects may include nausea, headache, and hypersensitivity reactions, while rare but serious effects include pulmonary toxicity and hepatotoxicity. Monitoring renal function prior to and during therapy is advisable. Martifur MR 100mg Tablet offers an effective and convenient treatment option for urinary tract infections, promoting optimal patient outcomes when used according to prescribed guidelines.